A
$ Value
$0
Shares
33,435
Price
$0
Filed
Mar 10
Insider
Name
Leaman John Harold
Title
—
CIK
0001586657
Roles
Director
Transaction Details
Transaction Date
2026-03-08
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
33,435
Footnotes
Represents stock options awarded by the Issuer's compensation committee (comprised of independent directors) to the reporting person under the Issuer's 2021 Incentive Compensation Plan, as amended and/or restated through the date hereof. The stock options under this award will vest 100% on the first anniversary of the grant date.
Filing Info
Leaman John Harold's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-08 | TRAW | A | $0 |
| 2025-12-12 | TRAW | A | $0 |
| 2025-12-12 | TRAW | A | $0 |
| 2025-11-21 | TRAW | A | $0 |
| 2025-10-01 | TRAW | A | $0 |
Other Insiders at TRAW (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| STOVER JACK E | — | — | 2026-03-08 |
| CAUTREELS WERNER | — | — | 2026-03-08 |
|
Dukes Iain D.
Chief Executive Officer
|
— | — | 2026-03-08 |
| Shoemaker Mary Teresa | — | — | 2026-03-08 |
| Clarke Trafford | — | — | 2026-03-08 |
|
Savchuk Nikolay
Chief Operating Officer
|
— | — | 2026-03-08 |
|
Pauza Charles David
Chief Science Officer Virology
|
— | — | 2026-03-08 |
|
Redfield Robert
Chief Medical Officer
|
— | — | 2026-03-08 |
|
Parker Charles Nolan
Chief Financial Officer
|
— | — | 2026-03-08 |